ESO Lymphoma Course
L

Biology of Anaplastic Large Cell Lymphomas (ALK+ and ALK-) & Breast Implant‐associated ALCL

By ESO Lymphoma Course FEATURING Laurence de Leval
By ESO Lymphoma Course FEATURING Laurence de Leval
20 views
September 12, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Related Content

AUTOPLAY
08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

07:54
5th SOHO Italy Annual Conference

SOHO Italy 2023: Challenges in the Histopathological Diagnosis of No…

Feat. S. Fratoni
18:24
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Challenging Cases in Rare T-Cell Lymphomas

Feat. S. Barta
34:43
Houston Methodist Hospital

Review and Updates of New and Upcoming Cytopathology Reporting Syste…

Feat. E. M. Jacobi
02:36
Loretta Nastoupil

FDA Grants Accelerated Approval for Pembrolizumab in Relapsed/Refrac…

25:39
2018 Pan Pacific Lymphoma Conference

Lymphomatoid Granulomatosis Biology and Treatment

Feat. W. Wilson
08:52
2018 Pan Pacific Lymphoma Conference

Concurrent Systemic and CNS Aggressive NHL: How to Manage?

Feat. P. Bierman
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
13:07
Moffitt Cancer Center

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Feat. J. Chavez
09:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…

Feat. J. Westin
06:33
Christopher Flowers

FDA Approval of Zanubrutinib in R/R FL: What You Need to Know

10:04
Tara Graff

How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…

11:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…

Feat. A. Herrera
20:18
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Will Immune Therapy Replace Transplant in Hematologic Malignancies?

Feat. R. Gale
08:23
Total Health

R/R DLBCL Case Discussion: 81 y/o Male Needing 3rd Line Treatment

Feat. J. Chandler, B. Randolph, M. Onciu
08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou